Alanyl-glutamine infusions to patients with acute pancreatitis.
In this study we infused different amounts of glutamyl-dipeptides (group 1: 1.5 g ALA-GLN + 3.5 g GLY-GLN, group 2: 20 g ALA-GLN, group 3: 40 g ALA-GLN) for a period of five days into patients with acute pancreatitis. In spite of this high amount of ALA-GLN administration we were not able to normalise the depleted glutamine pool of skeletal muscle in these catabolic patients.
Karner
J
J
1st Surgical University Clinic, Department of Pathophysiology, Vienna, Austria.
Roth
E
E